Press
For Immediate Release:
Contact: Pauline Barfield
Barfield Public Relations, Inc.
212-736-0404
Barfield736@aol.com
BLACK WOMEN OF FAITH AND MEDICINE: WORKING TOGETHER TO ERADICATE CERVICAL CANCER
THE BALM IN GILEAD INTRODUCES ITS NEW PUBLIC EDUCATION CAMPAIGN
Washington, D.C., January 11, 2007 – 100% Preventable.
Spread the Word.
Save a Sister. This is the new public education campaign message from the Balm
In Gilead’s 2007 ISIS Project (Intimate Sessions for Informed Sexuality).
National Spokesperson Estelle H. Whitney, MD; Anafidelia Tavares, MD,
MPH along
with 20 African-American female clinicians came together at a press conference
today at the Four Seasons Hotel to support the campaign and to announce the Balm
In Gilead’s new component of the ISIS Project: Black Women of Faith
and
Medicine: Working Together to Eradicate Cervical Cancer. The Balm In Gilead also
announced its new public education program for this year’s ISIS Project,
the goal of which is to inform and educate African-American women about cervical
cancer and to encourage them to take the HPV test and to become knowledgeable
about the HPV vaccine. The ISIS Project encourages African-American women between
the ages of 30 and 70 years old to become empowered to safeguard their health
by learning about HPV, cervical cancer and the need for regular screening with
the Pap test and HPV test.
The medical data speaks for itself:
- African-American women have the highest cervical cancer death rate
of any group of women and die at twice the rate of white women.
- Cervical cancer is caused by persistent infection with an extremely common
and contagious virus, the human papillomavirus (HPV); although there are approximately
15 cancer-causing HPV types, types 16 and 18 are responsible for 70% of all
cervical cancers worldwide.
-
Many women are not aware that cervical cancer is preventable and that new technologies
like the HPV test are an important weapon in the fight against cervical cancer.
-
African-American women are not aware of the vaccine against the disease that
is available for women under 26 years of age.
-
Almost one third of all women in the U.S. had no health insurance in 2005,
and some cannot pay for routine screenings like Pap tests or the HPV tests
or the now available vaccine.
-
New technologies including HPV testing for screening women and HPV vaccination
for girls offer new opportunities to prevent cervical cancer among African-American
women.
The ISIS Project was initially launched in March 2005 with the partnership
of the women’s societies of three major African-American religious denominations
(African Methodist Episcopal, African Methodist Episcopal Zion, and Christian
Methodist Episcopal) with a potential reach of 7 million African-Americans. “The
addition of the expertise of African American female clinicians to the ISIS
Project makes it a complete program that targets the heart and soul of Black
women across our nation,” states Pernessa Seele, Founder/CEO of the Balm
In Gilead. She further states, “Due to the centrality of the church in
African-American life, this program will be able to reach those who frequently
under use cancer screening services and the underinsured.”
Ten markets across the country will benefit from educational training program
on cervical cancer – The District of Columbia, Miami, Houston, Montgomery,
Oakland, Chicago, Greensboro, St. Louis, Greenville and Pittsburgh.
Estelle H. Whitney, MD, FACOG specializes in Obstetrics & Gynecology in
Newark, Delaware. She is a graduate of the Howard University School of Medicine.
Anafidelia Tavares, MD, MPH is Director of Women’s Health at the Balm
In Gilead, where she oversees the ISIS Project. She received her medical degree
at the Boston University School of Medicine and completed a Masters of Public
Health at the Harvard School of Public Health.
The ISIS Project will employ a peer educator strategy in each city. Drs. Whitney
and Tavares will conduct 2-day training sessions with 15 women recruited to
become peer educators per market. These trainees will become Balm In Gilead
Certified Cervical Cancer Peer Educators. After the training sessions, the
peer educators will go into the community and deliver five educational sessions
within a six month period. These sessions will include information on HPV and
cervical cancer, screenings and available vaccines, and how to discuss these
issues with health care professionals (role playing scenarios will be used).
Grass roots marketing materials (church event listings, flyers, pamphlets and
other handouts) will be utilized to solicit community participants to attend
the sessions.
In addition, the 20 African-American clinicians will serve as expert media
spokespersons in their respective markets regarding the overall medical issues
of cervical cancer.
With the launch of the ISIS project in 2005, the Balm In Gilead is dedicated
to educating women about cervical cancer and empowering them to get their annual
Pap test and HPV test if they are over 30 years of age. The campaign also wants
women to become knowledgeable about the vaccine.
The Balm In Gilead is a not-for-profit, non-governmental organization whose
mission is to improve the health status of people of the African Diaspora by
building the capacity of faith communities to address life-threatening diseases,
especially HIV/AIDS.
Over the past 18 years, The Balm In Gilead has earned worldwide recognition
as the leading organization in the United States dedicated to empowering and
mobilizing faith institutions to address life-threatening diseases, especially
HIV/AIDS within the African-American community and on the continent of Africa.
For additional information about the Balm In Gilead, visit our website at
www.balmingilead.org or call toll free: 1-888-225-6243.
Support for the ISIS Project is made possible through an unrestricted educational
grant from Digene and Merck Corporations.
Support for the ISIS Project is made possible through an unrestricted educational grant from Digene Corporation.
For additional information about The Balm In Gilead, visit our website www.balmingilead.org. Call toll free in the United States 1-888-225-6243.